Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

At a time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical ...

Artificial intelligence (AI) is changing the way companies do business -- helping programmers write code and fielding ...

The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...

Artificial intelligence is changing the way industries do business. But executives in the pharmaceutical industry are still ...

After three years of mounting pressure from AIDS activists, the pharma companies finally dropped their case. While this story has a happy ending, Mandela’s battle against Big Pharma was only a ...

Hospitals account for about 30% of the $4.5 trillion the U.S. spends annually on healthcare, compared with 9% for drugs.

The last few years have been marked by many big pharma companies opting to move away from diversification and towards more focused operations. Ben Hargreaves explores what is driving this ...

“We advise the pharmaceutical companies we work for to be transparent ... understand that if you invest heavily and therefore run a big risk, your profits will be higher than for people who ...

Innate Pharma's cancer programs, including partnerships with big pharma, show promise. Find out why IPHA stock could offer ...